1. PRLog Home
  2. Business Index
  3. Pressroom Index
  4. Press Releases Home
  1. About
  2. Press Room
  3. Contact
Filter By Industry
Filter By Tag

Press Room

Nemucore Medical Innovations Press releases

1 - 10 of 14 Press Releases

Oct 02, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted therapies to treat patients afflicted with multidrug resistant cancers, today announced the publication of its...

Jul 21, 2014
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

Jun 24, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced its...

May 21, 2014
Worcester Polytechnic Institute grants Provost Award to Joseph Cacaccio and Eileen Wrabel for their major qualifying project work at Nemucore Medical Innovations.

Mar 25, 2014
Nemucore Medical Innovations, Inc. (NMI) is a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers.

Mar 24, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of targeted nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced its...

Mar 12, 2014
Nemucore Medical Innovations, Inc., a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the publication...

Feb 04, 2014
Nemucore Medical Innovations, Inc. (NMI), a privately-held biopharmaceutical company dedicated to the development and commercialization of nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the...

Jan 02, 2014
Nemucore Medical Innovations, Inc. (NMI), a nanomedicine company dedicated to the development and commercialization of life-saving nanomedicines for the treatment of patients afflicted with multidrug resistant cancers, today announced the appointment of..

May 08, 2013
Nemucore Medical Innovations, Inc. (NMI) announces it has received a Phase I U43 Small Business Innovation research grant from the National Cancer Institute.


Page:

RSS Feed for Nemucore Medical Innovations Press Releases